The Lancet Psychiatry

Oxford University VR spinout lands $4.1M for mental health product
By Laura Lovett | 09:46 am | September 20, 2018
Oxford VR, a virtual reality platform to treat mental health issues, has landed $4.1M to commercialize its technology. 
Study: Immersive VR therapy reduces individuals' fear of heights
By Dave Muoio | 04:04 pm | July 12, 2018
An investigation published yesterday in The Lancet Psychiatry found that automated cognitive intervention delivered via sessions with a consumer-grade virtual reality headset effectively reduced individuals’ fear of heights, and was generally well received by those participating in the study.